Search results
Results from the WOW.Com Content Network
Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [17] It is generally used by injection under the skin but may also be used by injection into a vein. [17] Maximum effect occurs after about 1–3 hours and lasts for 3–5 hours. [17]
Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 ... NovoLog FlexPen: Insulin aspart: 364,870: 7.84%: Novo Nordisk: Diabetes mellitus type 1 ...
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Novo Nordisk said Tuesday that its popular fast-acting insulins NovoLog and NovoLog Mix 70/30 will cost $72.34 for a single vial and $139.71 for a pen, a 75% decrease in price.
For premium support please call: 800-290-4726 more ways to reach us
By Sriparna Roy and Mariam Sunny (Reuters) -Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of ...
NovoLog/ insulin aspart injection: Software used: Preview: Conversion program: macOS Version 10.14.4 (Build 18E227) Quartz PDFContext: Encrypted: no: Page size: 612 x 792 pts (letter) Version of PDF format: 1.3
The unit, Optum Rx, will move eight products, including all short- and rapid-acting insulin, to tier one, or preferred status, which offers the lowest price for consumers and is effective Jan. 1.